Global Mammography Market

Global Mammography Market Size, Share, Growth Analysis, By Product(film screen systems, digital systems), By end use(hospitals, speciality clinics), By technology(breast tomosynthesis, CAD mammography) - Industry Forecast 2024-2031


Report ID: SQMIG35G2133 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 90 | Figures: 76

Global Mammography Market Insights

Mammography Market size was valued at USD 2 million in 2019 and is poised to grow from USD 2.2 million in 2023 to USD 4.63 million by 2031, growing at a CAGR of 10.1% in the forecast period (2024-2031).

Some of the main reasons projected to fuel demand for Mammography throughout the forecast period is the rising prevalence of breast cancer and the rising desire among patients for early-stage diagnosis. Some of the key elements anticipated to fuel the industry's growth include expanding government initiatives to promote clinical interpretation and increased access to breast cancer screening systems. For instance: To boost screening procedures in medically disadvantaged communities, the Health Resources & Services Administration (HRSA) launched a healthcare initiative. Breast Screen Australia is a joint effort by the federal, state, and territorial governments of Australia with the goal of lowering breast cancer-related morbidity and fatalities through early diagnosis. Every two years, women over 40 are entitled to a free mammogram, and those between the ages of 50 and 74 are strongly recommended to get screened.

The Goa government began offering free breast cancer screenings to 1 lakh women in October 2021. As part of this initiative, breast cancer screening will be done at 35 health centers throughout Goa. Thus, it is anticipated that these variables will have a favorable impact on the sector in the years to come. In addition, a significant share of women may live to be 60 or older due to the growing global population. About 78% of all breast cancer-related fatalities are women over the age of 60. The high incidence and mortality rate of breast cancer in this age group suggests that there is a sizable unmet need for breast cancer diagnostics. The necessity for mammography will probably increase as more incidents and fatalities occur. As a result, it is anticipated that the market would increase throughout the forecast period due to the growing elderly population. It is anticipated that the industry's release of new goods would increase end-user acceptance.

Earlier mammography equipment only produced 2D pictures of the breast, which had limitations on the quality of the interpretation. Craniocaudal (CC) and Mediolateral-Oblique (MLO) pictures are produced by 2D mammography systems. Due to tissue overlap and calcifications, which conceal malignant lesions, the flat appearance of these pictures makes it challenging for doctors to interpret images and diagnose tumors. A 3D picture of the breast may be obtained thanks to a new 3D-based technique called Digital Breast Tomosynthesis (DBT). Radiologists may now scan the breast slice by slice and spot anomalies that 2D pictures would have hidden.

US Mammography Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Mammography Market size was valued at USD 2 million in 2019 and is poised to grow from USD 2.2 million in 2023 to USD 4.63 million by 2031, growing at a CAGR of 10.1% in the forecast period (2024-2031).

As there are only a few significant companies in the mammography business, it is a consolidated market. The top market competitors are concentrating on advancing technology and minimizing the negative impacts of operations. To sustain their position in the marketplace, industry participants are actively involved in a number of strategic activities. 'Hologic Inc.', 'Fujifilm Corporation', ' GE Healthcare ', ' Siemens Healthineers ', ' Koninklijke Philips N.V. ', ' Metaltronica S.p.A. ', ' Planmed Oy ', ' Carestream Health, Inc. ', ' BMI Biomedical International S.r.l. ', ' Allengers Medical Systems Ltd. ', ' General Medical Italia S.p.A. ', ' Amico JSC ', ' Delphinus Medical Technologies, Inc. ', ' Aurora Imaging Technology, Inc. ', ' CMR Naviscan Corporation ', ' Micrima Limited ', ' iCAD Inc. ', ' KUB Technologies Inc. ', ' Solis Mammography ', ' Siemens AG '

The market should improve due to the increase in elderly populations, proactive efforts by clinical consideration relationships to reveal problems with early signs of breast cancer growth, and an increase in the frequency of breast diseases. The demand for mammography equipment is also fueled by improved reimbursement policies, increased government funding for research into breast disease, and mechanical advancements like breast tomosynthesis, which makes it easier for women with dense breast tissue to recognize the development of breast cancer.

Many organizations have taken concrete steps to treat these infections since people with breast cancer are more likely to get the infection. According to a study by Dafina Petrova et al., which appeared in the September 2020 issue of Medicina Clnica Journal, the Spanish Society of Medical Oncology (SEOM), the Spanish Society of Radiation Oncology (SEOR), and the European Society for Medical Oncology (ESMO) have released some guidelines on how to modify treatment regimens in order to reduce risks for cancer patients. The updated regulations would offer more effective ways to conduct operations, which would enhance the therapies. The market for digital mammography is anticipated to expand in response to situations like these. Due to the better representation of low-contrast objects, wider dynamic change, and enhanced diagnostic quality of pictures, particularly when analyzing thicker breasts, the use of digital mammography is changing in an increasing number of nations.

With a revenue share of over 36.4% in 2021, North America led the world market and is predicted to rise at a significant rate throughout the forecast period. One of the main variables influencing the local market is the increasing prevalence of breast cancer. The American Cancer Society estimates that in 2020, there will be around 276,480 new cases of invasive breast cancer in women. In addition, it has been determined that 48,530 women have in situ breast cancer, and it is anticipated that this figure will increase in the upcoming years. Additionally, a lot of businesses have started to launch efforts to support breast cancer screenings.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Mammography Market

Product ID: SQMIG35G2133

$5,300
BUY NOW GET FREE SAMPLE